Skip to main content
Signal8

Samuelson Doug

SEC insider (Form 3/4/5 filer). CIK 0001943326. Chief Financial Officer at Kairos Pharma, LTD. (KAPA) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Oct 8, 2025. Located in LOS ANGELES, CA.

Companies Samuelson Doug has filed insider reports for

  • Kairos Pharma, LTD. (KAPA): Officer, Chief Financial Officer
  • Sacks Parente Golf, Inc. (SPGC): Officer, Chief Financial Officer
Samuelson Doug profile photo

Samuelson Doug

CIK: 0001943326

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Kairos Pharma, LTD. logo
KAPA

Kairos Pharma, LTD.

Officer
Sacks Parente Golf, Inc. logo
SPGC

Sacks Parente Golf, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Kairos Pharma, LTD. logo
    KAPA

    Kairos Pharma, LTD.

    Oct 8, 2025
    Award
    Direct
    152.7K shares-
  • Kairos Pharma, LTD. logo
    KAPA

    Kairos Pharma, LTD.

    Nov 22, 2024
    Purchase
    Direct
    2.5K shares at avg. $1.50$4K
  • Sacks Parente Golf, Inc. logo
    SPGC

    Sacks Parente Golf, Inc.

    Sep 9, 2024
    Award

    Options to Purchase Common Stock

    Direct
    36K shares-

1-3 of 3